Evidence map›Paper›PMID 37123453›Full record

ArticleBioinformatics advances2023

Latent disease similarities and therapeutic repurposing possibilities uncovered by multi-modal generative topic modeling of human diseases.

Satoshi Kozawa, Hirona Yokoyama, Kyoji Urayama, Kengo Tejima, Hotaka Doi, Shunki Takagi, Thomas N Sato

Abstract read
In one paragraph

Article in Bioinformatics advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Satoshi KozawaKarydo TherapeutiX, Inc., Kyoto 619-0288, Japan.
Hirona YokoyamaKarydo TherapeutiX, Inc., Kyoto 619-0288, Japan.
Kyoji UrayamaKarydo TherapeutiX, Inc., Kyoto 619-0288, Japan.
Kengo TejimaKarydo TherapeutiX, Inc., Kyoto 619-0288, Japan.
Hotaka DoiKarydo TherapeutiX, Inc., Kyoto 619-0288, Japan.
Shunki TakagiKarydo TherapeutiX, Inc., Kyoto 619-0288, Japan.
Thomas N SatoKarydo TherapeutiX, Inc., Kyoto 619-0288, Japan.ORCID https://orcid.org/0000-0003-1023-9958

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Human diseases are characterized by multiple features such as their pathophysiological, molecular and genetic changes. The rapid expansion of such multi-modal disease-omics space provides an opportunity to re-classify diverse human diseases and to uncover their latent molecular similarities, which could be exploited to repurpose a therapeutic-target for one disease to another. Results: Herein, we probe this underexplored space by soft-clustering 6955 human diseases by multi-modal generative topic modeling. Focusing on chronic kidney disease and myocardial infarction, two most life-threatening diseases, unveiled are their previously underrecognized molecular similarities to neoplasia and mental/neurological-disorders, and 69 repurposable therapeutic-targets for these diseases. Using an edit-distance-based pathway-classifier, we also find molecular pathways by which these targets could elicit their clinical effects. Importantly, for the 17 targets, the evidence for their therapeutic usefulness is retrospectively found in the pre-clinical and clinical space, illustrating the effectiveness of the method, and suggesting its broader applications across diverse human diseases. Availability and implementation: The code reported in this article is available at: https://github.com/skozawa170301ktx/MultiModalDiseaseModeling. Supplementary information: Supplementary data are available at

Identifiers

PMID37123453
PMCPMC10133403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.